More medical technology muscle or the end of a gravy train? - UK probes private equity
This article was originally published in Clinica
Today sees the start of a crucial stage in the UK parliament's investigation of the private equity sector, which could revolutionise the regulation of buyout operations. From the venture capitalists eyeing the growing medtech start-up buyout market, to the private equity (PE) giants that are behind pan-sectoral UK takeovers worth up to $22bn, all have a vested interest in the outcome.